Company Filing History:
Years Active: 2012-2015
Title: Innovator Barry Sugarman: Transforming Diabetes Management
Introduction: Barry Sugarman is a prominent inventor based in San Diego, CA, who has made significant contributions to the field of diabetes management through his innovative patents. With a total of three patents to his name, Sugarman has focused on developing methods that improve the control of post-prandial glucose levels in diabetic subjects. His work has gained recognition within the medical community and has potential implications for diabetic care.
Latest Patents: Among his latest contributions, Barry Sugarman has patented a groundbreaking method for the control of post-prandial glucose. This method involves the administration of a fast-acting insulin analog alongside a hyaluronidase degrading enzyme. The unique aspect of this treatment is the timing; it is administered between 15 minutes before the meal and 30 minutes after commencing the meal. This innovation offers diabetic subjects a tailored approach to managing their glucose levels more effectively. Additionally, he has developed super fast-acting insulin compositions that utilize the same principles to enhance post-prandial glucose control, reinforcing his commitment to improving diabetic care.
Career Highlights: Sugarman currently works at Halozyme, Inc., a leading biotechnology company focused on developing innovative therapies for various medical conditions. His role at Halozyme allows him to collaborate with a team of experts and further advance his research in diabetes management. His contributions to the field are underscored by the impactful patents he has secured.
Collaborations: Throughout his career, Barry has worked closely with several notable professionals, including Gregory Ian Frost and Igor Bilinsky. These collaborations have contributed to the development of his innovative patents and expanded the reach of his research in diabetes management.
Conclusion: Barry Sugarman's work is a testament to the power of innovation in healthcare. By focusing on diabetes management, he has developed patents that hold promise for improving the lives of those living with diabetes. His collaborations with other experts demonstrate the importance of teamwork in advancing medical technology, positioning him as a key figure in the field of diabetes treatment.